Shares of Moderna dropped 4.76% to $123.47 at 09:49 EST on Tuesday, following last session’s upward trend. NASDAQ Composite is falling 0.87% to $12,998.50, after two successive sessions in a row of losses. This seems, at the moment, a somewhat negative trend exchanging session today.
Moderna’s last close was $129.72, 44.57% below its 52-week high of $178.50.
Moderna’s sales growth is 1986.4% for the current quarter and 19117.5% for the next. The company’s growth estimates for the present quarter and the next is 18.9% and 660%, respectively.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s last day, last week, and last month’s average volatility was a positive 4.56%, a positive 2.46%, and a negative 0.89%, respectively.
Moderna’s last day, last week, and last month’s high and low average amplitude percentage was 6.66%, 6.44%, and 8.42%, respectively.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $123.47 at 09:49 EST, way under its 52-week high of $178.50 and way above its 52-week low of $17.91.
Moderna’s Moving Average
Moderna’s worth is below its 50-day moving average of $133.81 and way above its 200-day moving average of $87.22.